Economic burden of antibiotic resistance: How much do we really know?

S. Gandra, D. M. Barter, R. Laxminarayan

Research output: Contribution to journalReview articlepeer-review

186 Scopus citations


The declining effectiveness of antibiotics imposes potentially large health and economic burdens on societies. Quantifying the economic outcomes of antibiotic resistance effectively can help policy-makers and healthcare professionals to set priorities, but determining the actual effect of antibiotic resistance on clinical outcomes is a necessary first step. In this article, we review and discuss the contributions and limitations of studies that estimate the disease burden attributable to antibiotic resistance and studies that estimate the economic burden of resistance. We also consider other factors that are important in a comprehensive approach to evaluating the economic burden of antibiotic resistance.

Original languageEnglish (US)
Pages (from-to)973-979
Number of pages7
JournalClinical Microbiology and Infection
Issue number10
StatePublished - Oct 1 2014

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases


  • Antibiotic resistance
  • Attributable morbidity and mortality
  • Economics


Dive into the research topics of 'Economic burden of antibiotic resistance: How much do we really know?'. Together they form a unique fingerprint.

Cite this